TRANSCRIPT

Q1 2023 — Prepared remarks

Q1 2023PDF · 13 pages226 KB
1
Philip Morris International Inc.
2023 First-Quarter Conference Call
April 20, 2023
JAMES BUSHNELL
(SLIDE 1.)
Welcome. Thank you for joining us. Earlier today, we issued a press release containing
detailed information on our 2023 first-quarter results. You may access the release on
www.pmi.com.
(SLIDE 2.)
A glossary of terms, including the definition for smoke-free products as well as
adjustments, other calculations and reconciliations to the most directly comparable
U.S. GAAP measures for non-GAAP financial measures cited in this presentation, and
additional net revenue data are available in Exhibit 99.2 of the company's Form 8-K
dated April 20, 2023 and on our Investor Relations website.
Growth rates presented on an organic basis reflect currency-neutral adjusted results
excluding acquisitions and disposals. As such, figures and comparisons presented on
an organic basis exclude Swedish Match up until November 11, 2023.
(SLIDE 3.)
Today’s remarks contain forward-looking statements and projections of future results.
I direct your attention to the Forward-Looking and Cautionary Statements disclosure
in today’s presentation and press release for a review of the various factors that could
cause actual results to differ materially from projections or forward-looking statements.
It is now my pleasure to introduce Emmanuel Babeau, Chief Financial Officer.
Over to you, Emmanuel.

-- 1 of 13 --

2
EMMANUEL BABEAU
(SLIDE 4.)
Thank you, James, and welcome everyone.
I am pleased to report that Q1 performance exceeded our expectations, with strong
underlying momentum from IQOS, ZYN and our combustible business. As mentioned
at our full-year earnings in February, we expected this quarter to be the weakest of the
year due to a confluence of transitory factors impacting our top- and bottom-line. In
this context, our business delivered robust results and we look forward with confidence
to the remainder of the year.
Smoke-free net revenues made up almost 35% of total PMI, despite the impact of
adverse timing factors on HTU shipments, with an increasing number of markets
crossing the 50% threshold.
IQOS continues to deliver strong share and user growth across its geographies, both
with the blade version and ILUMA. Where launched, ILUMA’s excellent traction with
both existing IQOS users and legal-age smokers is boosting growth, demonstrating
the dynamism and importance of our ongoing innovation. ILUMA’s progress is
especially notable in the first launch market of Japan, where share growth has
accelerated in recent quarters.
In combustibles, accelerated pricing across a range of markets helped to deliver robust
organic net revenue growth.
Swedish Match delivered impressive results, with a stand-out performance from ZYN’s
47% U.S. shipment volume growth compared to the first quarter of 2022.
Following an encouraging start to the year, we are well set up to deliver strong
performance in 2023 including excellent top- and bottom-line growth for the remainder
of the year.
(SLIDE 5.)
Turning to the headline numbers, our Q1 organic net revenues saw robust growth of
3.2% against a very strong prior year quarter with organic growth of 9%. This reflects
the continued strength of IQOS and a step-up in pricing but was partially offset by
expected HTU inventory movements, which I will come back to. This organic figure
does not include the excellent 14% ex-currency top-line growth of Swedish Match, led
by ZYN. Our total reported currency-neutral net revenues grew by 9.6%, with

-- 2 of 13 --

3
combined pro forma adjusted net revenues increasing by around 4%, also excluding
currency.
Our total organic net revenue per unit grew by 4.4% with strong combustible pricing of
7.4% partially offset by HTU dynamics in Japan and Germany, which I will come back
to momentarily.
We delivered Q1 adjusted diluted EPS of $1.38, well above our previous expectations.
This reflects a strong underlying delivery from our existing operations, excellent
Swedish Match performance, and favorable phasing on interest costs. Compared to a
record high prior year quarter, and with a number of one-off or accentuated margin
headwinds from inflation, supply chain inefficiencies and timing factors as flagged
previously, our adjusted diluted EPS contracted by 4.4%.
(SLIDE 6.)
Let me now walk through the mechanics of our Q1 net revenues. We delivered overall
adjusted net revenue growth of 4.6% on an organic shipment volume decline of 1.1%.
While not included in this number, Swedish Match’s smoke-free volumes grew by an
excellent 10% – adding impressive accretion to our overall growth profile.
Combustible and HTU pricing, excluding Germany and Japan HTUs, contributed 5.3
points of growth, including positive HTU pricing in a number of markets.
This was partly offset by a negative 1.3 point HTU impact from Germany and Japan.
The larger of the two was Germany, reflecting a full quarter of the 2022 excise tax
increase for which we await a court ruling later this year. In Japan, the October 2022
excise tax increase and transition to ILUMA were also a drag on our top-line, and we
expect some of this impact to phase out in the second half.
While the increasing mix of HTUs in our business, at higher net revenue per unit,
continues to positively impact our performance, lower shipments in Europe this quarter
due to wholesaler and distributor inventory movements limited the benefit. This was
also the main driver for the difference between our smoke-free organic net revenue
growth and HTU shipment volume growth. We expect this positive mix shift to
accelerate as both smoke-free organic net revenue growth and HTU shipment growth
align more closely with offtake trends for the year, as they also did in 2022. The positive
mix impact of HTUs, overall volume growth, and pricing are powerful drivers of our
transformation and growth.

-- 3 of 13 --

4
(SLIDE 7.)
As expected, the first quarter was impacted by peak margin headwinds at both the
gross margin and adjusted operating income level. Our gross margin contracted by
0.6 percentage points due to the net impact of COGS inflation, pricing, volume, mix
and productivity savings. We expect the positive elements of pricing, productivities
and favorable HTU category mix to increasingly compensate and ultimately outweigh
inflation as we progress through the year.
Supply chain disruption and the accelerated transition of consumers and our business
to ILUMA accounted for a further 0.6pp impact. We anticipate these items to abate as
we progress with ILUMA launches and gain efficiencies in our supply chain, including
a return to sea freight.
In addition, specific cost phasing and the geographic mix of inventory movements,
notably for HTUs in Europe, impacted our gross margin by 1.8pp in the quarter.
Despite these exceptional Q1 dynamics, we continue to forecast the full-year 2023
margin impact of our heat-not-burn business to be favorable as inventory movements
and ILUMA-related factors dissipate.
Therefore, and as explained previously, we expect a progressive improvement in our
gross profit and OI margins, notably weighted towards H2 as headwinds subside and
the underlying drivers of our transformation accelerate.
(SLIDE 8.)
At around 26% of adjusted net revenues, our Q1 SG&A costs are at a similar ratio to
the full-year 2022. However, as expected there was a notable increase compared to
Q1, 2022 given lower commercial spend at the beginning of last year, the inflationary
environment, cost phasing, and front-loaded commercial investments.
Our successful cost efficiencies program continues to deliver, enabling ongoing
investment and helping to mitigate inflation, with $150 million of gross savings realized
in Q1 of which almost $50 million were from SG&A.
Importantly, we expect a significant slow-down in SG&A growth to a level below the
rate of net revenue growth for the remainder of the year – which will support OI margin
improvement.
(SLIDE 9.)
This brings me to the outlook for 2023. Our robust Q1 performance supports visibility
on strong full year growth. We continue to expect 7% to 8.5% organic top-line

-- 4 of 13 --

5
progression, with a targeted acceleration in HTU shipment volume growth versus
2022. As detailed in this morning’s press release, our other operating assumptions
remain unchanged, and we remind you that our organic metrics do not include the
contribution from Swedish Match for the large majority of the year.
Our updated full year adjusted diluted EPS forecast of $6.10 to $6.22 includes an
estimated unfavorable currency impact of 30 cents. Positive estimated impacts from
the Euro and a number of other currencies are outweighed mainly by the weakness of
the Japanese Yen, as well as the significant depreciation of the Russian Ruble and
the Egyptian Pound.
This range continues to reflect 7% to 9% currency-neutral growth and does not include
any contribution from a potential favorable excise tax ruling in Germany, which we
would expect to add around 3 points to our adjusted diluted EPS related to 2023 tax
payments. We continue to expect Swedish Match to be low single-digit accretive to
our 2023 adjusted diluted EPS after financing, and for an increase of around $200
million in our non-acquisition related interest costs, despite a relatively modest
increment in Q1.
As discussed at full-year earnings in February, this year’s bottom-line results are
expected to be notably H2-weighted. However, we expect our organic net revenue
growth to already accelerate in the second quarter into the high single-digits. We
forecast second quarter HTU shipment volumes of between 30 and 32 billion, with
adjusted diluted EPS in the range of $1.42 to $1.47, including an estimated
unfavorable currency impact of 13 cents. Looking ahead to the second half of the year,
we expect close to double-digit organic top-line growth and a return to margin
expansion.
(SLIDE 10.)
Looking at our full-year forecast through a different lens, after the temporary
headwinds in Q1 we expect very strong performance for the remainder of the year.
Despite ongoing margin headwinds and investments, we expect organic top-line
growth of 8% to 10%, improving margins with expansion in H2 and currency-neutral
adjusted diluted EPS growth of 10% to 13%. This reflects the strong underlying drivers
of our transformation, with IQOS and ZYN driving volumes at a higher net revenue per
unit, combined with stepped-up pricing on combustibles.
(SLIDE 11.)
Turning back to our Q1 results, our HTU adjusted IMS volumes grew by an estimated
16%, demonstrating continued strong growth momentum.

-- 5 of 13 --

6
HTU shipment volumes of 27.4 billion units were toward the higher end of our forecast
range, with growth of 10.4%, which was well below actual offtake trends as anticipated,
due to distributor and wholesaler inventory movements. As implied by our full-year
HTU shipment forecast, we expect the rate of shipment growth to accelerate for the
rest of the year as shipments converge with consumer offtake, and to grow at a faster
pace in 2023 than in 2022.
Before detailing these inventory impacts, it's important to note that in certain markets,
such as Germany, IMS sales volumes are not measured at the point of distributor sales
to the retail trade, as the data is not available. In these cases we instead use our
shipments as the proxy. This means that shipment fluctuations can impact both IMS
volumes and reported market share, and may not be representative of offtake
dynamics. Given the volatility seen over this quarter and from now on, where there is
a significant difference between estimated offtake performance and IMS data, we may
choose to provide market share metrics based on adjusted IMS to better reflect
offtake, where adjustments reflect the total estimated impact of distributor and
wholesaler inventory movements. As you may note in the appendix to today’s earnings
release this is the case for Germany this quarter, where we also provide historical
figures.
Coming back to Q1, HTU shipment volumes in several European markets were below
consumer offtake. This is explained by the reversal of some inventory build-ups at the
end of Q4, 2022 to meet the needs of ILUMA launches, as mentioned at our full-year
results in February, and also to create some safety stock to mitigate the risk of
production and distribution constraints due to energy shortages. As anticipated, we
were able to adjust this safety stock in Q1 as the risk receded. We also decreased the
level of IQOS blade HTU inventories in several markets to reduce the risk of obsolete
stock given the rapid transition to ILUMA. Notably impacted markets include Italy and
Germany, where underlying market share and offtake trends remained strong. Italian
Q1 IMS volumes grew by 21% compared to the prior year, with market share
increasing from 15.4% in Q4 to 17.4% in Q1. In Germany, adjusted Q1 IMS volumes
increased over 30% from the prior year with adjusted market share up from 4.7% in
Q4 to 5.3% in Q1.
Now turning back to the overall picture, while total Q1 cigarette and HTU shipment
volumes declined by 1.1%, our total IMS volumes were essentially stable and grew
excluding total estimated inventory movements.
Our cigarette shipments declined by 3.1%, with resilient trends in many markets. The
decline includes a notable impact from a high prior year comparison in Japan and the
introduction of an abrupt excise tax increase in Pakistan, resulting in an increase in
illicit trade and an industry contraction of over 30%. Volumes also declined in the

-- 6 of 13 --

7
Philippines following industry pricing, with consumer purchasing power facing ongoing
pressure.
We continue to target stable to positive combined cigarette and HTU shipment
volumes for the year, following growth in 2021 and 2022. This notably does not include
the excellent growth prospects of oral nicotine, for which shipment volumes grew by
10% in Q1.
Most importantly, the exciting growth combination of IQOS and ZYN presents an
unrivalled platform for growth over the coming years.
(SLIDE 12.)
Focusing now on combustibles, our portfolio delivered robust Q1 organic net revenue
growth of 3%. This reflects strong pricing of 7.4% with a step-up across many markets
including Germany, Indonesia, and the Philippines. With over 80% of planned 2023
combustible pricing implemented or announced, we have good visibility on the full year
delivery, although some of the positive Q1 variance reflects earlier pricing compared
to 2022. We now forecast a full-year variance of 6% to 7%.
Our cigarette category share declined by 0.3pp in Q1, which was essentially all
attributable to geographic mix as the total industry declined in large volume markets
such as the Philippines and Pakistan. The impact of share movements within markets
was neutral, with gains including Egypt, Poland, and Turkey offset by declines in
markets such as Ukraine, the Philippines, and Iraq.
Importantly, we continue to target a stable category share in 2023 and over time,
despite the impact of IQOS cannibalization.
(SLIDE 13.)
Moving now to our smoke-free products, we estimate there were 25.8 million IQOS
users as of March 31st. This represents growth of close to 1 million adult users since
December with notable progress in Japan and Europe, in addition to a broad range of
other geographies.
(SLIDE 14.)
IQOS ILUMA has been a positive catalyst for volume and share growth across a broad
range of launch markets, both supporting our strong position in the heat-not-burn
category with a superior user experience, and fostering further category growth.

-- 7 of 13 --

8
For existing IQOS users, ILUMA drives an accelerated upgrade cycle. This enhances
retention and full conversion for the future, with a temporary margin impact from
concentrated device sales. Indeed, we are now approaching an estimated 10 million
ILUMA users with ILUMA taking over 85% of HTU volumes in the first launch markets
of Japan, Switzerland, and Spain.
ILUMA is also enabling better acquisition and conversion of legal-age smokers, with
market share acceleration visible in both earlier and more recently launched markets
such as Italy and Korea. Since the introduction in these two markets in Q4, we are
seeing encouraging trends in initial launch areas and expect this to be increasingly
visible at the national level over time as it is in Japan and Greece, after a seasonal
inflection in the latter.
Our main focus in Q1 was on ensuring the success of ILUMA in the 16 markets
launched by the end of 2022, which cover over half of our IQOS business by volumes.
In addition, we launched ILUMA on a limited basis in Indonesia in February via our
IQOS club members program. The IQOS club was introduced in 2019 and now has
over 100 thousand estimated users across 10 cities, with a notable boost from the
launch of ILUMA. We expect to progressively launch ILUMA in more markets this year.
With ILUMA accelerating IQOS growth where launched, PMI HTUs continue to
strengthen their position as the second largest nicotine 'brand' in markets where IQOS
is present with a record high share of 9.0% in Q1. Impressively, as of Q1 PMI HTUs
are now the #1 nicotine ‘brand’ in 10 markets with the addition of Italy and Greece
during the quarter.
(SLIDE 15.)
Focusing now on Europe, which under our new regional structure includes additional
markets such as Ukraine. Our first quarter HTU share increased by 1.7 points to reach
9.2% of total cigarette and HTU industry volume, adjusted for estimated wholesaler
and distributor inventory movements, such as those I mentioned earlier in Germany
and Italy. On the same adjusted basis, IMS volumes continued to grow sequentially
and reached a record high of 11.1 billion units on a four-quarter moving average. This
reflects strong progress across the region.
We expect our Europe HTU volumes to grow strongly in the remainder of the year
while, as in the past, our quarterly HTU share of market can be impacted by
seasonality of cigarette consumption during Q2 and Q3.
(SLIDE 16.)
To give some further color on our outstanding progress in the region, slide 16 shows
a selection of the latest key city offtake shares.

-- 8 of 13 --

9
The success of IQOS continues across a diverse range of geographies from Western,
Southern, Central and Eastern Europe including markets with and without ILUMA.
Notable stand-outs include Budapest with over 35% offtake share as well as Rome
and Athens reaching the high twenties. To my earlier comments, we are very pleased
with performance in Germany, where offtake share in Munich surpassed 10% for the
first time.
We are also encouraged by recent positive regulatory developments in Greece where
the Ministry of Health approved differentiated health claims for heated tobacco
products. Greece is the first country outside of the United States that permitted health-
related statements following a robust scientific assessment.
(SLIDE 17.)
In Japan, the heat-not-burn category now represents over 35% of total tobacco with
IQOS driving category growth. The acceleration seen in recent quarters continued in
Q1. Adjusted total tobacco share for our HTU brands increased by 3.4 points to 26.2%
with offtake share surpassing 32% in Tokyo and 30% in Sendai. Adjusted IMS volumes
again grew sequentially, reaching a record high of 9.0 billion units on a four-quarter
moving average.
Strong performance in Japan further highlights the importance of continuous
innovation and a broad consumable portfolio. Our premium-priced TEREA HTUs and
mainstream priced SENTIA HTUs continued to grow through Q1, strengthening their
position as the two largest heat-not-burn brands. We are delighted with the progress
in Japan and as we look forward to further robust volume growth in the coming
quarters, we would also like to remind you of the seasonality impact on quarterly share
metrics.
(SLIDE 18.)
In addition to strong IQOS gains in developed countries, we continue to see very
promising growth in Low and Middle-Income markets which are now approaching 30%
of our total HTU volumes.
This slide highlights a selection of Q1 key city offtake shares across markets in Eastern
Europe, the Middle East, Asia and Latin America. Notable successes include Bulgaria
with Sofia offtake share of over 16% and Egypt, where offtake share in Cairo reached
7.5%. We also continue to see robust offtake volume growth across these important
future markets.

-- 9 of 13 --

10
(SLIDE 19.)
Now moving on to Swedish Match’s business, which delivered an excellent Q1
performance with currency-neutral net revenue growth of 14% and smoke-free
products comprising 77% of total net revenues.
Most impressive was the continued outstanding performance of ZYN in the U.S. with
47% volume growth to 73 million cans. While volume growth benefited from inventory
movements, including restocking in California following the December flavor ban,
underlying growth in volumes was very strong, estimated well above 30%.
We are also pleased with the Q1 performance in other U.S smoke-free categories,
including moist snuff which gained 0.8pp category share and delivered shipment
volume growth of 3%.
The smoke-free category in Scandinavia continued to grow driven by nicotine
pouches, albeit at a slower rate following January snus excise tax increases in Sweden
and Norway, with destocking accentuating the volume decline for Swedish Match’s
premium-skewed snus portfolio.
In cigars, the business delivered positive pricing and robust shipment volume growth
of 4% in a declining category driven by the strong development of natural leaf varieties.
Finally, I would like to congratulate Swedish Match’s employees for continuing to
deliver excellent results as we thoughtfully integrate our activities. The integration is
progressing very well and we look forward to sharing more on our combined growth
plans later this year.
(SLIDE 20.)
Now let’s examine ZYN’s recent U.S. performance in more detail. Superb progress
continues with a record increase in 12-month rolling shipment volumes of 23 million
cans, which equates to 40% growth.
Category volume share remained essentially stable despite continued heavy
competitive discounting from less premium offerings. Importantly, retail value share for
ZYN also remains strong at 75.6%, highlighting its premium positioning and superior
brand equity.

-- 10 of 13 --

11
(SLIDE 21.)
There are two key engines driving the U.S. growth of ZYN, as covered at CAGNY. First
is the progressive increase in distribution, with the number of stores 13% higher than
Q1, 2022 at around 140,000. There remains ample opportunity to further increase this
over time.
Second are velocities, or the number of cans sold per store per week. ZYN velocities
continue to grow sequentially and by an impressive 21% compared to prior year as
the brand continues to resonate with adult nicotine users.
(SLIDE 22.)
Now, let me update you on our exciting plans to further accelerate our smoke-free
journey.
As previously mentioned, the full global roll-out of IQOS ILUMA is a major priority. We
are on track to make substantial progress this year as HTU manufacturing constraints
continue to ease.
We continue to work on our IQOS U.S. commercialization plans for launch in Q2 2024,
in line with the principles outlined at the recent CAGNY conference. With the benefit
of the expertise and commercial tools from launching IQOS successfully in over 70
international markets, and a U.S. market with a clear regulatory framework and the
ability to communicate with adult smokers, we remain very positive about the
opportunity. Importantly, we believe we can make the necessary investments in the
U.S. business, generating additional top-line performance while continuing to deliver
strong bottom-line growth for PMI during the investment period.
In addition to our premium offerings, we are continuing to focus on BONDS, our latest
heat-not-burn innovation that is especially relevant for Low- and Middle-Income
consumers. Pilot launches in the Philippines and Colombia are progressing well and
we intend to continue taking the learnings from these markets before deploying on a
wider scale.
Another key mid-term opportunity from the Swedish Match combination is the
international expansion of nicotine pouches, notably with ZYN – the world’s leading
brand. At CAGNY I mentioned we are targeting up to ten launches or relaunches this
year as we look to develop the category with adult smokers who value the
convenience, specific use occasions, taste, and satisfaction. We expect this to
commence in a few markets this summer, including both developed and emerging
countries.

-- 11 of 13 --

12
While staying clearly focused on the heat-not-burn and nicotine pouch categories,
which present the largest and most accretive growth opportunities, we are adjusting
our VEEV e-vapor portfolio and approach. We intend to focus on commercializing in
select markets and prioritizing profitability given the known category challenges. VEEV
ONE is a new pod-based system providing an enhanced user experience with fully
outsourced manufacturing of devices and consumables to optimize costs. VEEV ONE
will replace the current VEEV product and, as a result, we no longer intend to file a
PMTA for the former technology. Instead, we will focus our near-term FDA
engagements on IQOS and ZYN. We will come back on future e-vapor FDA
authorizations in due course.
For disposables, the fastest growing e-vapor segment, we are rebranding VEEBA to
VEEV NOW. All of our e-vapor products will now be under the single, recognizable
brand VEEV for a seamless consumer experience.
We will introduce the new VEEV ONE platform in Canada later this month and will
apply an agile and disciplined approach for further VEEV roll-outs later this year.
(SLIDE 23.)
Moving to sustainability, I want to first draw your attention to our 2022 Integrated
Report published earlier this month, which outlines the progress we are making
towards achieving our purpose and smoke-free future. The report provides a
comprehensive run-through of all our most material sustainability topics. This includes
those in focus for investors such as post-consumer waste, youth access prevention,
decarbonization, and our resource allocation towards advancing our smoke-free
transformation.
In conjunction with the Integrated Report, we also published an updated ESG KPI
Protocol providing even more robust criteria on how we define success and measure
ESG performance. It focuses on the KPIs included in our Sustainability Index, which
as outlined in our 2023 proxy statement continue to represent 30% of our long-term
performance-based equity executive compensation.
I am also proud to announce that we released our first TCFD Report yesterday, which
updates and compiles our previous disclosures on how we are implementing the
recommendations of the Task Force on Climate-related Financial Disclosures in one
document. This will be an important topic for many companies as reporting regulations
evolve.

-- 12 of 13 --

13
Lastly, we are also pleased that, following CDP’s triple A recognition, PMI was again
included in CDP’s supplier engagement leaderboard, contributing towards achieving
our scope 3 ambitions.
(SLIDE 24.)
To conclude today’s presentation, we are on track for strong performance in 2023
despite margin headwinds. Our underlying growth fundamentals remain strong, and
we expect these headwinds to progressively ease through the year.
Indeed, we delivered higher-than-expected Q1 results which put us on-track for the
third consecutive year of high single-digit organic net revenue growth.
Continued excellent IQOS and ZYN performance further enhances our position as the
global smoke-free champion with leadership positions in the largest category of heat-
not-burn and the fastest growing category of oral nicotine. We are taking action
through pricing in combustibles and our cost savings initiatives to recover cost
inflation, as we progress rapidly toward our ambition to become a majority smoke-free
business.
Finally, we remain a highly cash generative business with an unwavering commitment
to our progressive dividend policy. We look forward to further rewarding our
shareholders as our transformation delivers sustainable growth.
(SLIDE 25.)
Thank you. We are now happy to answer your questions.
JAMES BUSHNELL
(SLIDE 26.)
That concludes our call today. Thank you again for joining us. If you have any follow-
up questions, please contact the Investor Relations team. Thank you again and have
a nice day.

-- 13 of 13 --